NCT02261532 2024-11-14
A Phase I Study of TAS-102 in Solid Tumors
Taiho Pharmaceutical Co., Ltd.
Phase 1 Completed
Taiho Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co. Ltd
3D Medicines
Gustave Roussy, Cancer Campus, Grand Paris
Jiangsu Simcere Pharmaceutical Co., Ltd.
Synta Pharmaceuticals Corp.
Nerviano Medical Sciences